PASWNasdaqApparel & Other Finishd Prods of Fabrics & Similar Matl

Ping An Biomedical Co., Ltd.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 30, 2026

$0.13+0.01 (+8.07%)

Close on Oct 19, 2026

Ping An Biomedical Co., Ltd. income statement

AnnualQuarterlyTTM

Millions of CNY, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30
Revenue	34	88	83
Cost of Revenue	33	82	78
Gross Profit	0.95	5.42	4.24
Selling, General & Admin	6.31	5.30	3.60
Selling & Marketing	0.30	0.31	0.33
General & Administrative	6.01	4.99	3.27
Operating Expenses	16	5.42	3.63
Operating Income	-15	0.00	0.61
Interest Expense	0.31	0.71	1.74
Interest & Investment Income	0.33	0.00	0.16
Other Non-Operating Income	0.02	-0.68	-0.57
Pretax Income	-15	-0.68	0.04
Income Tax Expense	1.86	-0.60	-1.04
Net Income	-13	-1.28	-0.99
EPS (Basic)(per share)	-0.69	-0.07	-0.06
EPS (Diluted)(per share)	-0.69	-0.07	-0.06
Shares Outstanding (Basic, Weighted)(shares)	18	18	18
Shares Outstanding (Diluted, Weighted)(shares)	18	18	18

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2025

Gross margin: 2.8%
Operating margin: -43.1%
Net margin: -37.6%
Return on equity, FY2025: -67.4%

Financial strength

Current ratio: 2.54
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 31.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.